menu
    • menu

    Company profile for Voyager Therapeutics, Inc

    NEW Drugs in Dev: 10
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Voyager Therapeutics is committed to people living with severe neurological diseases. We plan to develop life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (A...
    Voyager Therapeutics is committed to people living with severe neurological diseases. We plan to develop life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (ALS) called SOD1, Huntington’s disease, Friedreich’s ataxia, Alzheimer’s disease, and other neurodegenerative diseases related to defective or excess aggregation of tau and alpha-synuclein protein in the brain.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Voyager Therapeutics, IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    75 Sidney St. Cambridge, MA 02139
    Telephone
    Telephone
    +1-857-259-5340
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.voyagertherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/voyager-therapeutics-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VoyagerTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Voyager to Present at H.C. Wainwright Neuro Perspectives
    Voyager to Present at H.C. Wainwright Neuro Perspectives

    11 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/11/3310782/36461/en/voyager-to-present-at-h-c-wainwright-7th-annual-neuro-perspectives-hybrid-conference.html

    GLOBENEWSWIRE
    11 Jun 2026
    Share Share
    Voyager Gets FDA Clearance For VY1706, Gene Therapy In Alzheimer
    Voyager Gets FDA Clearance For VY1706, Gene Therapy In Alzheimer

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304289/36461/en/voyager-receives-fda-ind-clearance-for-vy1706-first-gene-therapy-approach-to-reducing-tau-production-in-the-brain-for-alzheimer-s-disease.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Voyager Reports Positive VY1706 Safety Results
    Voyager Reports Positive VY1706 Safety Results

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293787/36461/en/voyager-asgct-late-breaker-single-iv-dose-of-vy1706-well-tolerated-reduced-tau-in-3-month-glp-toxicology-data-clinical-trial-in-alzheimer-s-disease-expected-h2-2026.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Voyager Reports First Quarter 2026 Financial & Operating Results
    Voyager Reports First Quarter 2026 Financial & Operating Results

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290505/36461/en/voyager-reports-first-quarter-2026-financial-and-operating-results.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Voyager Unveils Tau-Targeted VY1706 for Alzheimer's at ASGCT
    Voyager Unveils Tau-Targeted VY1706 for Alzheimer's at ASGCT

    27 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7211525

    FIRSTWORD PHARMA
    27 Apr 2026
    Share Share
    Voyager Pauses Alzheimer's Program 8 Months After Unveiling Med
    Voyager Pauses Alzheimer's Program 8 Months After Unveiling Med

    10 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/voyager-pauses-alzheimers-program-8-months-after-unveiling-asset

    FIERCE BIOTECH
    10 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search